OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
September 22, 2023
What impact will EMA’s decision to phase out COVID-19 regulatory flexibilities have on the pharma industry?
September 06, 2023
Further expansions of the pharmaceutical development and manufacturing services of ten23 are happening at the BASE and VIVA facilities to continue to support complex sterile product development, testing, and manufacturing.
July 24, 2023
The framework is now expanded beyond COVID-19 vaccines and treatments.
The paper highlights the potential of AI in the medicinal product lifecycle and the approach that developers should take with it.
July 20, 2023
These recommendations will keep key antibiotics for respiratory infections available when they are needed most.
July 13, 2023
The agency is reviewing the medicines after receiving reports of self-injury and suicidal thoughts in patients using the type 2 diabetes treatments.
May 17, 2023
The agency’s safety committee is reviewing hydroxyprogesterone medicines and issuing a reminder on safety issues regarding fluoroquinolone antibiotics.
The agency has published guidance on good practices for securing the supply of medicines.
The report outlines highlights from the agency’s medicines evaluations and milestones for 2022.
May 10, 2023
EMA and European regulators are lifting their COVID-19 business continuity measures as the pandemic’s peak ends.